Single anastomosis sleeve ileal bypass

Single anastomosis sleeve ileal bypass has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Nov 18, 2026: “Single-center experience with sasi bypass: mid-term outcomes and technical evolution”.

Exposure

1 paper studies it5 findingsUpdated

1 new paper in 30 daysSee all 1 papers on single anastomosis sleeve ileal bypass

At a glance

The findings reach people, from one lab or study. 1 lab.

“Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”
Single-center experience with sasi bypass: mid-term outcomes and technical evolutionLangenbeck's archives of surgery2026doi:10.1007/s00423-026-04362-2

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab
  • Humans1

What did studies of single anastomosis sleeve ileal bypass find?

5

Studies of single anastomosis sleeve ileal bypass measured 5 outcomes, among them gastroesophageal reflux disease symptoms, dyslipidemia and hypertension.

Gastroesophageal reflux disease symptoms

downin humans1

1 study
  1. Single anastomosis sleeve ileal bypass is linked with lower gastroesophageal reflux disease symptoms in humans (Patients affected by GERD) (Improvement in all affected patients; 57.9% complete remission).

    “GERD symptoms improved in all affected patients, with 57.9% achieving complete remission.”

    HumansPatients affected by GERD

    Single-center experience with sasi bypass: mid-term outcomes and technical evolution

    Langenbeck's archives of surgery

Dyslipidemia

downin humans1−86% remission

1 study
  1. Single anastomosis sleeve ileal bypass is linked with lower dyslipidemia in humans (Primary metabolic and bariatric surgery) (85.6% remission).

    “Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”

    HumansPrimary metabolic and bariatric surgery

    Single-center experience with sasi bypass: mid-term outcomes and technical evolution

    Langenbeck's archives of surgery

More on Dyslipidemia

Hypertension

downin humans1−89% remission

1 study
  1. Single anastomosis sleeve ileal bypass is linked with lower hypertension in humans (Primary metabolic and bariatric surgery) (89.1% remission).

    “Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”

    HumansPrimary metabolic and bariatric surgery

    Single-center experience with sasi bypass: mid-term outcomes and technical evolution

    Langenbeck's archives of surgery

More on Hypertension

Type 2 diabetes

downin humans1−78% remission

1 study
  1. Single anastomosis sleeve ileal bypass is linked with lower type 2 diabetes in humans (Primary metabolic and bariatric surgery) (78.3% remission).

    “Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”

    HumansPrimary metabolic and bariatric surgery

    Single-center experience with sasi bypass: mid-term outcomes and technical evolution

    Langenbeck's archives of surgery

More on Type 2 diabetes

Body weight

downin humans1

1 study
  1. Single anastomosis sleeve ileal bypass is linked with lower body weight in humans (Primary metabolic and bariatric surgery) (Mean total weight loss 33.0%).

    “Mean %TWL 33.0%.”

    HumansPrimary metabolic and bariatric surgery

    Single-center experience with sasi bypass: mid-term outcomes and technical evolution

    Langenbeck's archives of surgery

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months